Automated discovery of noncovalent inhibitors of SARS-CoV-2 main protease by consensus Deep Docking of 40 billion small molecules. Issue 48 (30th November 2021)
- Record Type:
- Journal Article
- Title:
- Automated discovery of noncovalent inhibitors of SARS-CoV-2 main protease by consensus Deep Docking of 40 billion small molecules. Issue 48 (30th November 2021)
- Main Title:
- Automated discovery of noncovalent inhibitors of SARS-CoV-2 main protease by consensus Deep Docking of 40 billion small molecules
- Authors:
- Gentile, Francesco
Fernandez, Michael
Ban, Fuqiang
Ton, Anh-Tien
Mslati, Hazem
Perez, Carl F.
Leblanc, Eric
Yaacoub, Jean Charle
Gleave, James
Stern, Abraham
Wong, Bill
Jean, François
Strynadka, Natalie
Cherkasov, Artem - Abstract:
- Abstract : Deep learning-accelerated docking coupled with computational hit selection strategies enable the identification of inhibitors for the SARS-CoV-2 main protease from a chemical library of 40 billion small molecules. Abstract : Recent explosive growth of 'make-on-demand' chemical libraries brought unprecedented opportunities but also significant challenges to the field of computer-aided drug discovery. To address this expansion of the accessible chemical universe, molecular docking needs to accurately rank billions of chemical structures, calling for the development of automated hit-selecting protocols to minimize human intervention and error. Herein, we report the development of an artificial intelligence-driven virtual screening pipeline that utilizes Deep Docking with Autodock GPU, Glide SP, FRED, ICM and QuickVina2 programs to screen 40 billion molecules against SARS-CoV-2 main protease (Mpro). This campaign returned a significant number of experimentally confirmed inhibitors of Mpro enzyme, and also enabled to benchmark the performance of twenty-eight hit-selecting strategies of various degrees of stringency and automation. These findings provide new starting scaffolds for hit-to-lead optimization campaigns against Mpro and encourage the development of fully automated end-to-end drug discovery protocols integrating machine learning and human expertise.
- Is Part Of:
- Chemical science. Volume 12:Issue 48(2021)
- Journal:
- Chemical science
- Issue:
- Volume 12:Issue 48(2021)
- Issue Display:
- Volume 12, Issue 48 (2021)
- Year:
- 2021
- Volume:
- 12
- Issue:
- 48
- Issue Sort Value:
- 2021-0012-0048-0000
- Page Start:
- 15960
- Page End:
- 15974
- Publication Date:
- 2021-11-30
- Subjects:
- Chemistry -- Periodicals
540.5 - Journal URLs:
- http://pubs.rsc.org/en/Journals/JournalIssues/SC ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/d1sc05579h ↗
- Languages:
- English
- ISSNs:
- 2041-6520
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3151.490000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 20178.xml